These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 32246002)

  • 1. Monitoring protease activity in biological tissues using antibody prodrugs as sensing probes.
    Vasiljeva O; Menendez E; Nguyen M; Craik CS; Michael Kavanaugh W
    Sci Rep; 2020 Apr; 10(1):5894. PubMed ID: 32246002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo imaging of protease activity by Probody therapeutic activation.
    Wong KR; Menendez E; Craik CS; Kavanaugh WM; Vasiljeva O
    Biochimie; 2016 Mar; 122():62-7. PubMed ID: 26546838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-specific activation of an EGFR-targeting probody enhances therapeutic index.
    Desnoyers LR; Vasiljeva O; Richardson JH; Yang A; Menendez EE; Liang TW; Wong C; Bessette PH; Kamath K; Moore SJ; Sagert JG; Hostetter DR; Han F; Gee J; Flandez J; Markham K; Nguyen M; Krimm M; Wong KR; Liu S; Daugherty PS; West JW; Lowman HB
    Sci Transl Med; 2013 Oct; 5(207):207ra144. PubMed ID: 24132639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Probody T Cell-Engaging Bispecific Antibody Targeting EGFR and CD3 Inhibits Colon Cancer Growth with Limited Toxicity.
    Boustany LM; LaPorte SL; Wong L; White C; Vinod V; Shen J; Yu W; Koditek D; Winter MB; Moore SJ; Mei L; Diep L; Huang Y; Liu S; Vasiljeva O; West J; Richardson J; Irving B; Belvin M; Kavanaugh WM
    Cancer Res; 2022 Nov; 82(22):4288-4298. PubMed ID: 36112781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The tumor targeting performance of anti-CD166 Probody drug conjugate CX-2009 and its parental derivatives as monitored by
    Chomet M; Schreurs M; Nguyen M; Howng B; Villanueva R; Krimm M; Vasiljeva O; van Dongen GAMS; Vugts DJ
    Theranostics; 2020; 10(13):5815-5828. PubMed ID: 32483421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activatable Zymography Probes Enable
    Soleimany AP; Kirkpatrick JD; Su S; Dudani JS; Zhong Q; Bekdemir A; Bhatia SN
    Cancer Res; 2021 Jan; 81(1):213-224. PubMed ID: 33106334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multispectral Photoacoustic Imaging of Tumor Protease Activity with a Gold Nanocage-Based Activatable Probe.
    Liu C; Li S; Gu Y; Xiong H; Wong WT; Sun L
    Mol Imaging Biol; 2018 Dec; 20(6):919-929. PubMed ID: 29736563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel Ex Vivo Zymography Approach for Assessment of Protease Activity in Tissues with Activatable Antibodies.
    Howng B; Winter MB; LePage C; Popova I; Krimm M; Vasiljeva O
    Pharmaceutics; 2021 Sep; 13(9):. PubMed ID: 34575469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probody Therapeutics: An Emerging Class of Therapies Designed to Enhance On-Target Effects with Reduced Off-Tumor Toxicity for Use in Immuno-Oncology.
    Autio KA; Boni V; Humphrey RW; Naing A
    Clin Cancer Res; 2020 Mar; 26(5):984-989. PubMed ID: 31601568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteases as activators for cytotoxic prodrugs in antitumor therapy.
    Weidle UH; Tiefenthaler G; Georges G
    Cancer Genomics Proteomics; 2014; 11(2):67-79. PubMed ID: 24709544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Probody therapeutics for targeting antibodies to diseased tissue.
    Polu KR; Lowman HB
    Expert Opin Biol Ther; 2014 Aug; 14(8):1049-53. PubMed ID: 24845630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Probody Therapeutic Design of
    Giesen D; Broer LN; Lub-de Hooge MN; Popova I; Howng B; Nguyen M; Vasiljeva O; de Vries EGE; Pool M
    Clin Cancer Res; 2020 Aug; 26(15):3999-4009. PubMed ID: 31953313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor efficacy and reduced toxicity using an anti-CD137 Probody therapeutic.
    Etxeberria I; Bolaños E; Teijeira A; Garasa S; Yanguas A; Azpilikueta A; Kavanaugh WM; Vasiljeva O; Belvin M; Howng B; Irving B; Tipton K; West J; Mei L; Korman AJ; Sega E; Olivera I; Cirella A; Ochoa MC; Rodriguez ME; Melero A; Sanmamed MF; Engelhardt JJ; Melero I
    Proc Natl Acad Sci U S A; 2021 Jun; 118(26):. PubMed ID: 34172583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative Systems Pharmacology Model of a Masked, Tumor-Activated Antibody.
    Stroh M; Sagert J; Burke JM; Apgar JF; Lin L; Millard BL; Michael Kavanaugh W
    CPT Pharmacometrics Syst Pharmacol; 2019 Sep; 8(9):676-684. PubMed ID: 31250966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional imaging of proteases: recent advances in the design and application of substrate-based and activity-based probes.
    Edgington LE; Verdoes M; Bogyo M
    Curr Opin Chem Biol; 2011 Dec; 15(6):798-805. PubMed ID: 22098719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Accessory Protease Inhibitor to Increase the Yield and Quality of a Tumour-Targeting mAb in Nicotiana benthamiana Leaves.
    Jutras PV; Marusic C; Lonoce C; Deflers C; Goulet MC; Benvenuto E; Michaud D; Donini M
    PLoS One; 2016; 11(11):e0167086. PubMed ID: 27893815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Covalent activity-based probes for imaging of serine proteases.
    Skorenski M; Ji S; Verhelst SHL
    Biochem Soc Trans; 2024 Apr; 52(2):923-935. PubMed ID: 38629725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity-based probes for the study of proteases: recent advances and developments.
    Serim S; Haedke U; Verhelst SH
    ChemMedChem; 2012 Jul; 7(7):1146-59. PubMed ID: 22431376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global Protease Activity Profiling Identifies HER2-Driven Proteolysis in Breast Cancer.
    Salcedo EC; Winter MB; Khuri N; Knudsen GM; Sali A; Craik CS
    ACS Chem Biol; 2021 Apr; 16(4):712-723. PubMed ID: 33765766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracellular proteolysis in cancer: Proteases, substrates, and mechanisms in tumor progression and metastasis.
    Radisky ES
    J Biol Chem; 2024 Jun; 300(6):107347. PubMed ID: 38718867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.